Utility of hemoglobin A1c for the identification of individuals with diabetes and prediabetes in a Chinese high risk population

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue 5, 2012, Pages 403-409

  Yang, Chun ^a   Liu, Yang ^a   Li, Xue ^a   Liang, Hongyan ^a   Jiang, Xiaofeng ^a  

^a Medical University   (China)

Author keywords

China; Diabetes mellitus; Hemoglobin A1c protein; Oral glucose tolerance test; Prediabetic

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHINESE; DIABETES MELLITUS; DIAGNOSTIC VALUE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 84865310921     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.689324     Document Type: Article

References (28)

1. World Health Organization. The world health report: primary healthcare-now more than ever. Geneva: WHO, 2008.
2. Gabbay KH, Hasty K, Breslow JL, Ellison RC, Bunn HF, Gallop PM. Glycosylated haemoglobin and long term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 1977;44:859-64. (Pubitemid 8104630)
3. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diab Care 2009; 32:1327-34.
4. American Diabetes Association. Diagnosis and classifi cation of diabetes mellitus. Diab Care 2010;33:S62-9.
5. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007;11:1-125.
6. American Diabetes Association. Screening for type 2 diabetes (position statement). Diab Care 2004;27:S11-4.
7. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
8. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore G, Narayan KM. The evolving diabetes burden in the United States. Ann Intern Med 2004;140: 945-50. (Pubitemid 38685285)
9. Goodall I, Colman PG, Schneider HG, McLean M, Barker G. Desirable performance standards for A1c analysis-precision, accuracy and standardisation. Clin Chem Lab Med 2007;45:1083-97.
10. http://www.who.int/diabetes/publications/report-hba1c-2011.pdf
11. American Diabetes Association: Diagnosis and classifi cation of diabetes mellitus. Diab Care 2004;27(Suppl. 1): S5-14.
12. Lawrence JM, Bennett P, Young A, Robinson AM. Screening for diabetes in general practice: cross-sectional population study. BMJ 2001;323:548-51. (Pubitemid 32835576)
13. Nakagami T, and the DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in fi ve populations of Asian origin. Diabetologia 2004;47:385-94. (Pubitemid 38491233)
14. D ECODE Study Group, European Diabetes Epidemiology Group. Is the current defi nition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diab Care 2003;26:688-96.
15. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004:141;413-20.
16. Nuwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on defi nition and intervention. Diab Med 2002;19: 708-23. (Pubitemid 35013848)
17. Williams DE, Cadwell BL, Cheng YJ, Cowie CC, Gregg EW, Geiss LS, Engelgau MM, Narayan KM, Imperatore G. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents. Pediatrics 2005;116:1122-6. (Pubitemid 46056417)
18. Heldgaard PE, Olivarius Nde F, Hindsberger C, Henriksen JE. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population- based, cross-sectional study of risk factors for cardiovascular disease. Diab Med 2004;21:363-70. (Pubitemid 38519673)
19. Lim SC, Tai ES, Tan BY, Chew SK, Tan CE. Cardiovascular risk profi le in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diab Care 2000;23:278-82.
20. R ohlfi ng CL, Rohlfi ng CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flegal KM, Eberhardt MS, Goldstein DE. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diab Care 2000;23:187-91. (Pubitemid 30071022)
21. Engelgau M.M., Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, Badran A, Sous ES, Ali MA. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes: diagnostic criteria and performance revised. Diab Care 1997;20:785-91. (Pubitemid 27202529)
22. Bao Y, Ma X, Li H, Zhou M, Hu C, Wu H, Tang J, Hou X, Xiang K, Jia W. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 2010;340:c2249.
23. Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diab Care 1998;21:1221-5. (Pubitemid 28365673)
24. Ministry of Health, Labour and Welfare. National Diabetes Survey, 2002, http://www.health-net.or.jp/data/menu05/ toukei/tonyo-h14.pdf [in Japanese].
25. Nakagami T, Tominaga M, Nishimura R, Yoshiike N, Daimon M, Oizumi T, Tajima N. Is the measurement of glycated hemoglobin A1c alone an effi cient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diab Res Clin Pract 2007;76:251-6. (Pubitemid 46400133)
26. Miyazaki M, Kubo M, Kiyohara Y, Okubo K, Nakamura H, Fujisawa K, Hata Y, Tokunaga S, Iida M, Nose Y, Ishibashi T; and the Hisayama study. Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia 2004;47:1411-5. (Pubitemid 39232427)
27. Buell C, KermahD, Davidson MB. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diab Care 2007;30:2233-5. (Pubitemid 47359021)
28. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diab Care 2000;23: 1770-3.